Processing math: 57%
Review

mTOR signaling in proteostasis and its relevance to autism spectrum disorders

  • Received: 24 October 2016 Accepted: 12 January 2017 Published: 19 January 2017
  • Proteins are extremely labile cellular components, especially at physiological temperatures. The appropriate regulation of protein levels, or proteostasis, is essential for all cells. In the case of highly polarized cells like neurons, proteostasis is also crucial at synapses, where quick confined changes in protein composition occur to support synaptic activity and plasticity. The accurate regulation of those cellular processes controlling protein synthesis and degradation is necessary for proteostasis, and its deregulation has deleterious consequences in brain function. Alterations in those cellular mechanisms supporting synaptic protein homeostasis have been pinpointed in autism spectrum disorders such as tuberous sclerosis, neurofibromatosis 1, PTEN-related disorders, fragile X syndrome, MECP2 disorders and Angelman syndrome. Proteostasis alterations in these disorders share the alterations in mechanistic/mammalian target of rapamycin (mTOR) signaling pathway, an intracellular pathway with key synaptic roles. The aim of the present review is to describe the recent literature on the major cellular mechanisms involved in proteostasis regulation in the synaptic context, and its association with mTOR signaling deregulations in various autism spectrum disorders. Altogether, the cellular and molecular mechanisms in synaptic proteostasis could be the foundation for novel shared therapeutic strategies that would take advantage of targeting common disorder mechanisms.

    Citation: Judit Faus-Garriga, Isabel Novoa, Andrés Ozaita. mTOR signaling in proteostasis and its relevance to autism spectrum disorders[J]. AIMS Biophysics, 2017, 4(1): 63-89. doi: 10.3934/biophy.2017.1.63

    Related Papers:

    [1] Xianyi Li, Xingming Shao . Flip bifurcation and Neimark-Sacker bifurcation in a discrete predator-prey model with Michaelis-Menten functional response. Electronic Research Archive, 2023, 31(1): 37-57. doi: 10.3934/era.2023003
    [2] Mengxin He, Zhong Li . Dynamic behaviors of a Leslie-Gower predator-prey model with Smith growth and constant-yield harvesting. Electronic Research Archive, 2024, 32(11): 6424-6442. doi: 10.3934/era.2024299
    [3] Jiange Dong, Xianyi Li . Bifurcation of a discrete predator-prey model with increasing functional response and constant-yield prey harvesting. Electronic Research Archive, 2022, 30(10): 3930-3948. doi: 10.3934/era.2022200
    [4] Yichao Shao, Hengguo Yu, Chenglei Jin, Jingzhe Fang, Min Zhao . Dynamics analysis of a predator-prey model with Allee effect and harvesting effort. Electronic Research Archive, 2024, 32(10): 5682-5716. doi: 10.3934/era.2024263
    [5] Yuan Tian, Hua Guo, Wenyu Shen, Xinrui Yan, Jie Zheng, Kaibiao Sun . Dynamic analysis and validation of a prey-predator model based on fish harvesting and discontinuous prey refuge effect in uncertain environments. Electronic Research Archive, 2025, 33(2): 973-994. doi: 10.3934/era.2025044
    [6] Kerioui Nadjah, Abdelouahab Mohammed Salah . Stability and Hopf bifurcation of the coexistence equilibrium for a differential-algebraic biological economic system with predator harvesting. Electronic Research Archive, 2021, 29(1): 1641-1660. doi: 10.3934/era.2020084
    [7] San-Xing Wu, Xin-You Meng . Hopf bifurcation analysis of a multiple delays stage-structure predator-prey model with refuge and cooperation. Electronic Research Archive, 2025, 33(2): 995-1036. doi: 10.3934/era.2025045
    [8] Érika Diz-Pita . Global dynamics of a predator-prey system with immigration in both species. Electronic Research Archive, 2024, 32(2): 762-778. doi: 10.3934/era.2024036
    [9] Yuan Tian, Yang Liu, Kaibiao Sun . Complex dynamics of a predator-prey fishery model: The impact of the Allee effect and bilateral intervention. Electronic Research Archive, 2024, 32(11): 6379-6404. doi: 10.3934/era.2024297
    [10] Jiani Jin, Haokun Qi, Bing Liu . Hopf bifurcation induced by fear: A Leslie-Gower reaction-diffusion predator-prey model. Electronic Research Archive, 2024, 32(12): 6503-6534. doi: 10.3934/era.2024304
  • Proteins are extremely labile cellular components, especially at physiological temperatures. The appropriate regulation of protein levels, or proteostasis, is essential for all cells. In the case of highly polarized cells like neurons, proteostasis is also crucial at synapses, where quick confined changes in protein composition occur to support synaptic activity and plasticity. The accurate regulation of those cellular processes controlling protein synthesis and degradation is necessary for proteostasis, and its deregulation has deleterious consequences in brain function. Alterations in those cellular mechanisms supporting synaptic protein homeostasis have been pinpointed in autism spectrum disorders such as tuberous sclerosis, neurofibromatosis 1, PTEN-related disorders, fragile X syndrome, MECP2 disorders and Angelman syndrome. Proteostasis alterations in these disorders share the alterations in mechanistic/mammalian target of rapamycin (mTOR) signaling pathway, an intracellular pathway with key synaptic roles. The aim of the present review is to describe the recent literature on the major cellular mechanisms involved in proteostasis regulation in the synaptic context, and its association with mTOR signaling deregulations in various autism spectrum disorders. Altogether, the cellular and molecular mechanisms in synaptic proteostasis could be the foundation for novel shared therapeutic strategies that would take advantage of targeting common disorder mechanisms.


    The interaction between two or more species has been an important and interesting issue in biology and ecology since the famous Lotka-Volterra model [1,2] was proposed. The interaction between different species will generate rich interesting dynamics of biological species, and exhibit the complexity and diversity [3,4]. Amensalism, as a typical type of interaction between the species, has been intensively considered in the last decades. Amensalism describes a basic biological interaction in nature, where one species inflicts harm on another not affected by the former, which means that it does not receive any costs or benefits to itself. The first pioneer work for the investigations of amensalism model is due to Sun [5], who, in 2003, proposed the following two-species amensalism model:

    {dxdt=r1x(k1xαyk1),dydt=r2y(k2yk2), (1.1)

    where x=x(t) and y=y(t) represent the population densities of two species at time t, respectively; r1 and k1 describe the intrinsic growth rate and the carrying capacity of the first species, respectively; r2 and k2 describe the intrinsic growth rate and the carrying capacity of the second species, respectively; α describes the effect of the second species on the first species. They explored the stability properties of all possible equilibria in system (1.1).

    Setting a11=r1k1, a12=r1αk1 and a22=r2k2, we can see that model (1.1) can be rewritten as

    {dxdt=x(r1a11xa12y),dydt=y(r2a22y), (1.2)

    where all parameters r1, r2, a11, a12, and a22 are positive real numbers.

    Ever since the first amensalism model was presented, the complicated dynamics of amensalism models have been studied extensively (see [6,7,8,9,10,11,12,13,14,15] and the references cited therein). For example, in [6], Guan and Chen considered a two-species amensalism model with Beddington-DeAngelis functional response and gave some comprehensive bifurcation and global dynamics of this system. Recently, Luo et al. [12] proposed an amensalism model with Holling-Ⅱ functional response and weak Allee effect for the first species, and discussed its local dynamics and global structure.

    In the real world, from the point of view of human needs, the management of renewable resources, the exploitation of biological resources, and the harvesting of populations are commonly practiced in forestry, fishery, and wildlife management [16,17,18]. Hence, it is necessary to introduce and to consider the harvesting of species in population models. During the last decade, population models with harvesting and the role of harvesting in the management of renewable resources have received significant attention from the researchers [19,20,21,22,23,24]. Generally speaking, there are three types of harvesting: 1) constant harvesting [25]; 2) linear harvesting [25]; 3) non-linear harvesting [26,27]. As is well known, non-linear harvesting is more realistic from biological and economical points of view [28]. In [26], Clark first proposed the non-linear harvesting term h(E,x)=qExcE+lx, which is called Michaelis-Menten type functional form of catch rate, here q is the catchability coefficient, E is the external effort devoted to harvesting, c and l are constants. After that, many scholars started to focus attention on the influence of the Michaelis-Menten type harvesting on the population systems [28,29,30,31,32,33,34]. For example, a reaction-diffusion predator-prey model with non-local delay and Michaelis-Menten type prey-harvesting was investigated by Zhang et al. [32], they obtained that the discrete and non-local delays are responsible for a stability switch in this system, and a Hopf bifurcation occurs as the delays pass through a critical value. In [33], Hu and Cao discussed a predator-prey system with the nonlinear Michaelis-Menten type predator harvesting and gave a detailed analysis of the stability and bifurcation for this system.

    These studies have shown that harvesting activity has important influence to dynamics of population systems and the harvested models can exhibit richer dynamics compared to the model with no harvesting. However, seldom did scholars consider the dynamical behaviors of an amensalism model with a harvesting term. Accordingly, inspired by the previous works, based on the system (1.2), we now introduce the Michaelis-Menten type harvesting to the second species, then we propose the following amensalism model:

    {dxdt=x(r1a11xa12y),dydt=y(r2a22y)qEycE+ly, (1.3)

    where the parameters r1, r2, a11, a12, and a22 are positive constants, and this term qEycE+ly represents Michaelis-Menten harvesting.

    Setting ¯t=r1t, ¯x=a11r1x, ¯y=a12r1y, α=a12qElr21, δ=r2r1, β=a22a12, γ=a12cElr1, and dropping the bars, then system (1.3) is transformed into

    {dxdt=x(1xy),dydt=y(δβy)αyγ+y. (1.4)

    The layout of this paper is arranged as follows. In the next section, the global dynamics including positivity and boundedness of solutions, number of equilibria, local asymptotical stability, codimension one bifurcations, dynamical behaviors near infinity, closed orbits analysis and global phase portraits are shown for system (1.4). Further, in Section 3, we also obtain the global dynamics of system (1.1) without harvesting term. Numerical simulations and discussions are displayed by Section 4 for demonstrating the theoretical results and the impact of harvesting term. Finally, a brief conclusion is presented in Section 5.

    In this section, we mainly investigate the global dynamics of system (1.4), which include the positivity and boundedness of solutions, the existence and local stability analysis of equilibria, all possible bifurcation behaviors and the global structure of system (1.4).

    Here, we give the positivity and boundedness of the solutions of model (1.4) in the region R2+={(x,y):x0,y0}.

    Lemma 2.1. All solutions of model (1.4) with positive initial value are positive for all t0.

    Proof. Solving model (1.4) with positive initial condition (x(0),y(0)) gives the result:

    x(t)=x(0)[expt0(1x(s)y(s))ds]>0,y(t)=y(0)[expt0(δβy(s)αγ+y(s))ds]>0.

    Therefore, we can easily see that each solution of model (1.4) starting from the positive initial condition (x(0),y(0)) still remains in the first quadrant.

    Lemma 2.2. All solutions of system (1.4) with positive initial value are bounded in region Ω={(x(t),y(t)):0x(t)<1 and 0y(t)<δβ} for the large enough time t.

    Proof. If the initial value is selected in R2+, each solution of model (1.4) remains positive from the above result. One can see

    ˙x<x(1x)

    from the first equation of model (1.4). And a standard comparison theorem shows that

    limtsupx(t)<1.

    Also, the following inequality

    ˙y<βy(δβy)

    is obtained from the second equation of system (1.4). It yields

    limtsupy(t)<δβ.

    Hence, there exists a sufficiently large time T, such that 0x(t)<1 and 0y(t)<δβ for t>T. In summary, all the solutions of system (1.4) are always bounded. Thus we complete the proof.

    Theorem 2.1. System (1.4) always has two boundary equilibria E0(0,0) and E1(1,0) for all positive parameters. For the existence of other equilibria, we have

    1) For the possible positive equilibria:

    i) if α>α, then system (1.4) has no positive equilibria;

    ii) if α=α and 0<δβγ<2β, then there is a unique positive equilibrium E33(1y3,y3);

    iii) if α<α<α, when α<δ+δγββγ and δβγ>0, or α=δ+δγββγ and 0<δβγ<2β, there is one positive equilibrium E31(1y1,y1); when α>δ+δγββγ and 0<δβγ<2β, there are two distinct positive equilibria E31(1y1,y1) and E32(1y2,y2);

    iv) if α=α and 0<δβγ<β, then E31 coincides with E1 and there is one positive equilibrium E32(1y2,y2), where y2=δβγβ;

    v) if 0<α<α and α>δ+δγββγ, then there is one positive equilibrium E32(1y2,y2).

    2) For the other possible boundary equilibria:

    i) if α>α, then system (1.4) has no other boundary equilibria; there is one boundary equilibrium E22(0,y2).

    ii) if α=α and δβγ>0, then there is a boundary equilibrium E23(0,y3);

    iii) if α<α<α and δβγ>0, then there are two distinct boundary equilibria E21(0,y1) and E22(0,y2);

    iv) if α=α and δβγ>0, then E21 coincides with E0 and there is one boundary equilibrium E22(0,y2), where y2=δβγβ;

    v) if 0<α<α, then

    Where α=(δ+βγ)24β, α=δγ, y1=δβγ(δ+βγ)24αβ2β, y2=δβγ+(δ+βγ)24αβ2β, and y3=δβγ2β.

    Proof. It is easy to see that system (1.4) always possesses two boundary equilibria given by E0(0,0) and E1(1,0) for all positive parameters.

    1) If x0 and y0, system (1.4) has a positive equilibrium which satisfies

    {x=1y,βy2(δβγ)y+αδγ=0. (2.1)

    For the positive equilibria, y must satisfy 0<y<1. Let Δ denote the discriminant of the second equation of (2.1), namely,

    Δ=(δ+βγ)24αβ, (2.2)

    and let

    α=(δ+βγ)24β. (2.3)

    Obviously, when 0<α<α, the second equation of (2.1) has two roots

    y1=δβγΔ2β  and  y2=δβγ+Δ2β.

    When α=α, the second equation of (2.1) has one root

    y3=δβγ2β.

    Let

    k(y)=βy2(δβγ)y+αδγ,

    and denote by

    α=δγ. (2.4)

    Then we have

    H1) if α>α, then k(0)>0;

    H2) if α=α, then k(0)=0;

    H3) if α<α, then k(0)<0.

    In addition, 0<αα, and α=α if and only if δ=βγ.

    Based on the above analysis, combining with H1), H2) and H3), we can derive that:

    ⅰ) If α>α, then Δ<0 which implies k(y)=0 has no real roots. So system (1.4) has no positive equilibria.

    ⅱ) If α=α, then Δ=0, so k(y)=0 has a unique real roots y3=δβγ2β, combing with the condition 0<y3<1, we get 0<δβγ<2β. In this situation, there exists a unique positive equilibrium E33(1y3,y3).

    ⅲ) If α<α<α, then Δ>0 and k(0)>0, implying k(y)=0 two positive real roots y1 and y2 if δβγ>0. Moreover, when k(1)<0, namely, α<δ+δγββγ, we have 0<y1<1<y2, that is, there is one positive point E31(1y1,y1); when k(1)=0 and the symmetry axis of k(y) is y=δβγ2β<1, namely, α=δ+δγββγ and 0<δβγ<2β, we have 0<y1<y2=1, which means there is one positive point E31(1y1,y1); when k(1)>0 and the symmetry axis of k(y) is y=δβγ2β<1, namely, α>δ+δγββγ and 0<δβγ<2β, we have 0<y1<y2<1, that is there are two different positive equilibria E31(1y1,y1) and E32(1y2,y2).

    ⅳ) If α=α, then Δ>0 and k(0)=0, hence k(y)=0 has two real roots y1=0 and 0<y2=δβγβ<1 if 0<δβγ<β, thus E31 coincides with E1 and there is one positive equilibrium E32(1y2,y2).

    ⅴ) If α<α, then Δ>0 and k(0)<0, so there are y1<0 and y2>0. When k(1)>0, i.e., α>δ+δγββγ, we get one positive root 0<y2<1, thus there exits one positive equilibrium E32(1y2,y2).

    The proof of the corresponding boundary equilibria in 2) is similar to that of 1), and hence omitted here. This completes the proof of Theorem 2.1.

    In the following, we focus on the local stability of each equilibrium of system (1.4).

    Theorem 2.2. For the boundary equilibria E0 and E1, the following statements are true.

    1) If 0<α<α, then E0 is a hyperbolic unstable node and E1 is a hyperbolic saddle.

    2) If α>α, then E0 is a hyperbolic saddle and E1 is a hyperbolic stable node.

    3) If α=α, then

    i) when δβγ, E0 and E1 are both saddle-nodes;

    ii) when δ=βγ, E0 is a non-hyperbolic saddle and E1 is a non-hyperbolic stable node.

    Proof. The Jacobian matrix of system (1.4) evaluated at any equilibrium is

    J(x,y)=(2x+1yx0H(x,y)), (2.5)

    where H(x,y)=δ2βyαγ(γ+y)2.

    For the equilibrium E0, the Jacobian matrix is

    J(E0)=(100δαγ), (2.6)

    and the two eigenvalues of J(E0) are λ1(E0)=1>0 and λ2(E0)=δαγ. Obviously, if 0<α<α, then λ2(E0)>0, so E0 is a hyperbolic unstable node. If α>α, then λ2(E0)<0, thus E0 is a hyperbolic saddle. If α=α, then λ2(E0)=0, this means that the equilibrium E0 is non-hyperbolic, so it is hard to directly judge its type from their eigenvalues. We further discuss its stability properties by applying Theorem 7.1 in Chapter 2 in [35].

    In order to change system (1.4) into a standard form, we expand system (1.4) in power series up to the fourth order around the origin

    {dxdt=xx2xyx+P(x,y),dydt=(αγ2β)y2αγ3y3+αγ4y4+Q0(y)Q(x,y), (2.7)

    where Q0(y) represents a power series with the terms yi (i5). From dxdt=0, we obtain that there is a unique implicit function x=φ0(y)=0 such that φ0(y)+P(φ0(y),y)=0 and φ0(0)=φ0(0)=0. Then substituting x=φ0(y)=0 into the second equation of (2.7), we get that

    dydt=(αγ2β)y2αγ3y3+αγ4y4+O(|y|5). (2.8)

    Because α=α=δγ, the coefficient at y2 is δγβ. By Theorem 7.1 in [35], we have when δβγ, the equilibrium E0 is a saddle-node.

    When δ=βγ, (2.8) becomes

    dydt=βγy3+βγ2y4+O(|y|5). (2.9)

    Employing the notations of Theorem 7.1 in Chapter 2 in [35], we have m=3 and am=βγ<0, so the equilibrium E0 is a non-hyperbolic saddle.

    For the equilibrium E1, the Jacobian matrix is

    J(E1)=(110δαγ). (2.10)

    The two eigenvalues of the above matrix J(E1) are λ1(E1)=1<0 and λ2(E1)=δαγ. Clearly, if α<α, then λ2(E1)>0, so E1 is a hyperbolic saddle. If α>α, then λ2(E1)<0, then E1 is a hyperbolic stable node. If α=α, then λ2(E1)=0, the equilibrium E1 is non-hyperbolic and its stability cannot be given directly from the eigenvalues. In order to determinate the stability of E1, we translate E1 to the origin by the translation (¯x,¯y)=(x1,y) and expand system (1.4) in power series up to the fourth order around the origin, which makes system (1.4) to be the following form:

    {d¯xdt=¯x¯y¯x¯y¯x2,d¯ydt=(αγ2β)¯y2αγ3¯y3+αγ4¯y4+Q1(¯y), (2.11)

    where Q1(¯y) represents a power series with terms ¯yi (i5).

    To transform the Jacobian matrix into a standard form, we use the invertible translation

    (uv)=(1101)(¯x¯y), (2.12)

    then system (2.11) becomes

    {dudt=uu2+uv+(αγ2β)v2αγ3v3+αγ4v4+Q1(v),dvdt=(αγ2β)v2αγ3v3+αγ4v4+Q1(v). (2.13)

    By introducing a new time variable τ=t, we get

    {dudτ=u+u2uv(αγ2β)v2+αγ3v3αγ4v4Q1(v)u+P(u,v),dvdτ=(βαγ2)v2+αγ3v3αγ4v4Q1(v)Q(u,v). (2.14)

    Based on the implicit function theorem, from dudτ=0, we can deduce a unique function

    u=φ1(v)=(αγ2β)v2+(αγ2αγ3β)v3+(αγ2αγ3+αγ4β(αγ2β)2)v4+,

    which satisfies φ1(0)=φ1(0)=0 and φ1(v)+P(φ1(v),v)=0. Then substituting it into the second equation of (2.14), we have

    dvdτ=(βαγ2)v2+αγ3v3αγ4v4+O(|v|5). (2.15)

    From α=δγ it follows that the coefficient at v2 is βδγ. Thus, by using Theorem 7.1 in Chapter 2 in [35], we get that when δβγ, the equilibrium E1 is a saddle node.

    When δ=βγ, (2.15) can be written as

    dvdτ=βγv3βγ2v4+O(|v|5).

    By Theorem 7.1 in [35] again, we obtain m=3 and am=βγ>0. Then E0 is a non-hyperbolic unstable node. Hence, E1 is a non-hyperbolic stable node due to that we have used the transformation τ=t. Accordingly, Theorem 2.2 is proved.

    Theorem 2.3. For the boundary equilibria E21, E22 and E23, the following statements are true.

    1) Assume α=α and δβγ>0, then there exists the boundary equilibrium E23(0,y3). Moreover,

    i) If δβγ>2β, then E23 is a saddle-node, which includes a stable parabolic sector.

    ii) If 0<δβγ<2β, then E23 is a saddle-node, which includes an unstable parabolic sector.

    iii) If δβγ=2β, then E23 is non-hyperbolic.

    2) Assume α<α<α and δβγ>0, then there are two boundary equilibria E21(0,y1) and E22(0,y2). Moreover,

    i) If α<δ+δγββγ, then E21 is a hyperbolic unstable node and E22 is a hyperbolic stable node.

    ii) If α>δ+δγββγ and δβγ>2β, then E21 is a hyperbolic saddle and E22 is a hyperbolic stable node.

    iii) If α>δ+δγββγ and 0<δβγ<2β, then E21 is a hyperbolic unstable node and E22 is a hyperbolic saddle.

    iv) If α=δ+δγββγ and δβγ>2β, then E21 a saddle-node, which includes an unstable parabolic sector and E22 is a hyperbolic stable node.

    v) If α=δ+δγββγ and 0<δβγ<2β, then E21 a hyperbolic unstable node and E22 is a saddle-node, which includes a stable parabolic sector.

    3) Assume α=α and δβγ>0, then there is one boundary equilibrium E22(0,y2), where y2=δβγβ. Moreover,

    i) If 0<δβγ<β, then E22 is a hyperbolic saddle.

    ii) If δβγ=β, then E22 is a saddle-node, which includes a stable parabolic sector.

    iii) If δβγ>β, then E22 is a hyperbolic stable node.

    4) Assume 0<α<α, then there is one boundary equilibrium E22(0,y2).

    i) If α<δ+δγββγ, then E22 is a hyperbolic stable node.

    ii) If α=δ+δγββγ, then E22 is a saddle-node, which includes a stable parabolic sector.

    iii) If α>δ+δγββγ, then E22 is a hyperbolic saddle.

    Proof. For the equilibrium E2i(i = 1, 2, 3), the Jacobian matrix is

    J(E2i)=(1yi00H(xi,yi)), (2.16)

    where H(xi,yi)=δ2βyiαγ(γ+yi)2. The two eigenvalues of the above matrix J(E2i) are λ1(E2i)=1yi and λ2(E2i)=H(xi,yi).

    Because (xi,yi) satisfies δβyiαγ+yi=0, we can derive

    H(xi,yi)=δ2βyiαγ(γ+yi)2=2βyiγ+yi(yiδβγ2β).

    Then

    λ2(E21)=H(x1,y1)=2βy1(γ+y1)2(y1δβγ2β)=2βy1(γ+y1)2Δ2β>0,
    λ2(E22)=H(x2,y2)=2βy2(γ+y2)2(y2δβγ2β)=2βy2(γ+y2)2Δ2β<0

    and

    λ2(E23)=H(x3,y3)=2βy3(γ+y3)2(y3δβγ2β)=0.

    In addition, for λ1(E2i)=1yi, we discuss it in the following four cases.

    Case 1. α=α and δβγ>0.

    If δβγ>2β, then y3>1, which implies λ1(E23)=1y1<0, so E23 is non-hyperbolic. In order to determinate the stability of the equilibrium E23, we translate E23 to the origin by letting (¯x,¯y)=(x,yy3), and expand the system in power series up to the third order around the origin, under which system (1.4) can be transformed into

    {d¯xdt=(1y3)¯x¯x¯y¯x2,d¯ydt=c0¯y+c1¯y2+c2¯y3+Q2(¯y), (2.17)

    where c0=δ2βy3αγ(γ+y3)2=0, c1=αγ(γ+y3)3β, c2=αγ(γ+y3)4, and Q2(y) represents for a power series with terms ¯yi (i4).

    Then introducing a new time variable τ=(1y3)t, we get

    {d¯xdτ=¯x11y3¯x¯y11y3¯x2¯x+P(¯x,¯y),d¯ydτ=c11y3¯y2+c21y3¯y3+11y3Q2(¯y)Q2(¯x,¯y). (2.18)

    We see that the coefficient at ¯y2 is c11y3>0. Hence, from Theorem 7.1 in Chapter 2 of [35], we have E23 is a saddle-node, which includes a stable parabolic sector and this parabolic sector is on the upper half-plane.

    If δβγ<2β, then y3<1, which means λ1(E23)=1y1>0. Same analysis as the above we can get E23 is also a saddle-node, which includes an unstable parabolic sector and the parabolic sector is on the lower half-plane.

    If δβγ=2β, then y3=1, which means λ1(E23)=1y1=0, so E23 is a non-hyperbolic critical point with two zero eigenvalues.

    Case 2. α<α<α and δβγ>0.

    1) If α<δ+δγββγ, then y1<1<y2, that implies λ1(E21)=1y1>0 and λ1(E22)=1y2<0, so E21 is a hyperbolic unstable node and E22 is a hyperbolic stable node;

    2) If α>δ+δγββγ and δβγ>2β, then 1<y1<y2, implying λ1(E21)=1y1<0 and λ1(E22)=1y2<0, thus E21 is hyperbolic saddle and E22 is hyperbolic stable node;

    3) If α>δ+δγββγ and δβγ<2β, then y1<y2<1, that means λ1(E21)=1y1>0, λ1(E22)=1y2>0, hence E21 is a hyperbolic unstable node and E22 is a hyperbolic saddle;

    4) If α=δ+δγββγ and δβγ>2β, then 1=y1<y2, which means λ1(E21)=1y1=0 and λ1(E22)=1y2<0, so E21 is non-hyperbolic and E22 is a hyperbolic stable node.

    In order to determinate the stability of the equilibrium E21, we translate the equilibrium E21 to the origin by the translation (¯x,¯y)=(x,y1), and expand system (1.4) in power series up to the third order around the origin, which makes system (1.4) to be the following form:

    {d¯xdt=¯x¯y¯x2,d¯ydt=d0¯y+d1¯y2+d2¯y3+Q3(¯y), (2.19)

    where d0=δ2βαγ(γ+1)2, d1=αγ(γ+1)3β, d2=αγ(γ+1)4, and Q3(¯y) represents for a power series with terms ¯yi satisfying i4.

    Then introducing a new time variable τ=d0t, we get

    {d¯xdτ=1d0¯x¯y1d0¯x2Q(¯x,¯y),d¯ydτ=¯y+d1d0¯y2d2d0¯y3+1d0Q3(¯y)¯y+P(¯x,¯y). (2.20)

    From d¯ydτ=0, we can derive a unique implicit function ¯y=ϕ(¯x)=0, which satisfies ϕ(0)=ϕ(0)=0 and ϕ(¯x)+P(¯x,ϕ(¯x))=0. Substituting ¯y=ϕ(¯x)=0 into the first equation of (2.20), we have that

    d¯xdτ=1d0¯x2.

    The coefficient at ¯x2 is

    1d0=γ+1δβγ2β<0.

    By Theorem 7.1 in Chapter 2 of [35], we know E21 is a saddle-node, which includes an unstable parabolic sector and this parabolic sector is on the left half-plane.

    5) If α=δ+δγββγ and δβγ<2β, then y1<y2=1, implying λ1(E21)=1y1>0 and λ1(E22)=1y2=0, therefore E21 a hyperbolic unstable node and E22 is non-hyperbolic. Similarly to the proof of E21 in 4), we can get that E22 is a saddle-node, which includes a stable parabolic sector.

    Case 3. α=α and δβγ>0.

    If δβγ>β, then y2>1, that is λ1(E22)=1y2<0, so E22 is a hyperbolic stable node. If δβγ<β, then y2<1, that is λ1(E22)=1y2>0, thus E22 is a hyperbolic saddle. If δβγ=β, then y2=1, that is λ1(E22)=1y2=0, thus E22 is a non-hyperbolic. Similar to the proof of E21 in 4), we can obtain E22 is a saddle-node, which includes a stable parabolic sector.

    Case 4. α<α.

    If α>δ+δγββγ, then y2<1, which implies λ1(E22)=1y2>0, thus E22 is a hyperbolic saddle. If α<δ+δγββγ, then y2>1, which means λ1(E22)=1y2<0, thus E22 is a hyperbolic stable node. If α=δ+δγββγ, then y2=1, which implies λ1(E22)=1y2=0, thus E22 non-hyperbolic. Similar to the proof of 4) in Case 2, we can derive E22 is a saddle-node, which includes a stable parabolic sector.

    This completes the proof of Theorem 2.3.

    Theorem 2.4. For the positive equilibria E31, E32 and E33, the following statements are true.

    1) If α<α<α, when α<δ+δγββγ and δβγ>0, or α=δ+δγββγ and 0<δβγ<2β, or α>δ+δγββγ and 0<δβγ<2β, then E31 is a hyperbolic saddle.

    2) If 0<α<α and α>δ+δγββγ, or α=α and 0<δβγ<β, or α<α<α, α>δ+δγββγ and 0<δβγ<2β, then E32 is a hyperbolic stable node.

    3) If α=α and 0<δβγ<2β, then E33 is a saddle-node.

    Proof. For the equilibrium E3i(i = 1, 2, 3), the Jacobian matrix is

    J(E3i)=(yi1yi10H(xi,yi)), (2.21)

    where H(xi,yi)=δ2βyiαγ(γ+yi)2. The two eigenvalues of the above matrix J(E3i) are λ1(E3i)=yi1<0 and λ2(E3i)=H(xi,yi). From the analysis of the proof of Theorem 2.3, it follows that λ2(E31)>0, λ2(E32)<0, and λ2(E33)=0.

    Hence, when α<α<α, α<δ+δγββγ and δβγ>0, or α<α<α, α=δ+δγββγ and 0<δβγ<2β, or α<α<α, α>δ+δγββγ and 0<δβγ<2β, we have λ1(E31)<0 and λ2(E31)>0, which means E31 is a hyperbolic saddle.

    When 0<α<α and α>δ+δγββγ, or α=α and 0<δβγ<β, or α<α<α, α>δ+δγββγ and 0<δβγ<2β, there exists the positive equilibrium E32 with two eigenvalues λ1(E32)<0 and λ2(E32)<0, hence E32 is a hyperbolic stable node.

    When α=α and 0<δβγ<2β, there exists the positive equilibrium E33 with two eigenvalues λ1(E33)<0 and λ2(E33)=0. Then we further to study the stability of E33 by transforming E33 to the origin by the translation (¯x,¯y)=(xx3,yy3) and expand system (1.4) in power series up to the third order around the origin, which makes system (1.4) to be the following form:

    {d¯xdt=x3¯xx3¯y¯x¯y¯x2,d¯ydt=c0+c1¯y+(αγ(γ+y3)3β)¯y2αγ(γ+y3)4¯y3+Q4(¯y), (2.22)

    where c0=δy3β(y3)2α+αγγ+y3=0, c1=δ2βy3αγ(γ+y3)2=0, and Q4(¯y) stands for a power series with terms ¯yi (i4).

    In order to transform the Jacobian matrix into a standard form, we use the invertible translation

    (uv)=(1101)(¯x¯y), (2.23)

    then system (2.22) can be expressed as

    {dudt=x3u+uvu2+(αγ(γ+y3)3β)v2αγ(γ+y3)4v3+Q4(v),dvdt=(αγ(γ+y3)3β)v2αγ(γ+y3)4v3+Q4(v). (2.24)

    Then introducing a new time variable τ=x3t, we get

    {dudτ=u1x3uv+1x3u21x3(αγ(γ+y3)3β)v2+αγx3(γ+y3)4v31x3Q4(v)    u+P(u,v),dvdτ=1x3(αγ(γ+y3)2β)v2+αγx3(γ+y3)4v31x3Q4(v)Q(u,v). (2.25)

    According to the implicit function theorem, from dudτ=0, we can derive a unique function

    u=φ4(v)=1x3(αγ(γ+y3)3β)v2+1(x3)2(αγ(γ+y3)3β)v2αγx3(γ+y3)4v3+,

    which satisfies φ4(0)=φ4(0)=0 and φ4(v)+P(φ4(v),v)=0. Substituting it into the second equation of (2.25), we have that

    dvdτ=1x3(αγ(γ+y3)2β)v2+αγx3(γ+y3)4v3+O(|v|4).

    The coefficient at the term v2 is

    1x3(βαγ(γ+y3)2)=1x3(β(δβy3)γγ+y3)=β(δβγ)x3(δ+βγ)>0.

    Therefore, on basis of Theorem 7.1 in [35], the equilibrium E33 of system (1.4) is a saddle-node.

    The proof of Theorem 2.4 is finished.

    For readers' convenience, the local dynamical properties of equilibria of system (1.4) are totally summarized in Table 1. It can be clearly seen that the number and stability of equilibria are different according to the value range of the parameters. Therefore, we divide (α,β,γ,δ)R4+ into the following twelve regions.

    R11={(α,β,γ,δ)R4+:α=α,δ=βγ, or α=α,δ=βγ or α>α};R12={(α,β,γ,δ)R4+:α=α,δ<βγ};R2a={(α,β,γ,δ)R4+:0<α<α,αδ+δγββγ};R2b={(α,β,γ,δ)R4+:α=α,δβγβ};R22={(α,β,γ,δ)R4+:α=α,δβγ2β};R3a={(α,β,γ,δ)R4+:0<α<α,α>δ+δγββγ};R3b={(α,β,γ,δ)R4+:α=α,0<δβγ<β};R32={(α,β,γ,δ)R4+:α<α<α,αδ+δγββγ,δβγ>2β};R33={(α,β,γ,δ)R4+:α=α,0<δβγ<2β};R41={(α,β,γ,δ)R4+:α<α<α,α<δ+δγββγ,δ>βγ};R42={(α,β,γ,δ)R4+:α<α<α,α=δ+δγββγ,0<δβγ<2β};R5={(α,β,γ,δ)R4+:α<α<α,α>δ+δγββγ,0<δβγ<2β}.
    Table 1.  Equilibria of system (1.4) in finite planes.
    Conditions Equilibra
    0<α<α α<δ+δγββγ E0(u),E1(sd),E22(s)
    α=δ+δγββγ E0(u),E1(sd),E22(sn)
    α>δ+δγββγ E0(u),E1(sd),E22(sd),E32(s)
    α=α 0<δβγ<β E0(sn),E1(sn),E22(sd),E32(s)
    δβγ=β E0(sn),E1(sn),E22(sn)
    δβγ>β E0(sn),E1(sn),E22(s)
    δ=βγ E0(sd),E1(s)
    δ<βγ E0(sn),E1(sn)
    α<α<α α<δ+δγββγ δβγ>0 E0(sd),E1(s),E21(u),E22(s),E31(sd)
    α=δ+δγββγ 0<δβγ<2β E0(sd),E1(s),E21(u),E22(sn),E31(sd)
    δβγ>2β E0(sd),E1(s),E21(sn),E22(s)
    α>δ+δγββγ 0<δβγ<2β E0(sd),E1(s),E21(u),E22(sd),E31(sd),E32(s)
    \delta-\beta\gamma > 2\beta E_0(sd), E_1(s), E_{21}(sd), E_{22}(s)
    \alpha=\alpha^{*} 0 < \delta-\beta\gamma < 2\beta E_0(sd), E_1(s), E_{23}(sn), E_{33}(sn)
    \delta-\beta\gamma=2\beta E_0(sd), E_1(s), E_{23}(nh)
    \delta-\beta\gamma > 2\beta E_0(sd), E_1(s), E_{23}(sn)
    \delta-\beta\gamma=0 E_0(sd), E_1(s)
    \alpha > \alpha^{*} E_0(sd), E_1(s)
    Note: where "sd", "sn", "u", "s" and 'nh" represent saddle, saddle-node, unstable node, stable node and non-hyperbolic point, respectively.

     | Show Table
    DownLoad: CSV

    For R_1 = R_{11}\cup R_{12} , system (1.4) possesses two equilibria E_0 and E_1 . In R_{11} , E_0 is a saddle and E_1 is a stable node. In R_{12} , E_0 and E_1 represent saddle-nodes. And specifically, in R_1 , E_1 is stable in the first quadrant. Therefore, the qualitative properties of these two equilibria can be seen in Figure 1(a).

    Figure 1.  The qualitative properties of the equilibria for R_{1} , R_{2} , R_{3} , R_{4} and R_{5} .

    For R_2 = R_{21}\cup R_{22} , there are three equilibria for system (1.4). In R_{21} = R_{2a}\cup R_{2b} , system (1.4) admits E_0 (unstable node or saddle-node), E_1 (saddle or saddle-node) and E_{22} (stable node or saddle-node). In particular, in R_{21} , E_0 is unstable and E_{22} is stable in the first quadrant. In R_{22} , there are E_0 (saddle), E_1 (stable node) and E_{23} (non-hyperbolic or saddle-node). The qualitative properties of these equilibria in R_2 are displayed by Figure 1(b), (c).

    For R_3 = R_{31}\cup R_{32}\cup R_{33} , there exist four equilibria for system (1.4). Considering R_{31} = R_{3a}\cup R_{3b} , there are E_0 (unstable node or saddle-node which is unstable in the first quadrant), E_1 (saddle or saddle-node), E_{22} (saddle) and E_{32} (stable node). Considering R_{32} , system (1.4) admits E_0 (saddle), E_1 (stable node), E_{21} (saddle or saddle-node) and E_{22} (stable node). Considering R_{33} , there exist E_0 , E_1 , E_{23} and E_{33} , which are saddle, stable node, saddle-node and saddle-node. The detailed image descriptions of the qualitative properties of the equilibria in R_3 are illustrated by Figure 1(d)(f).

    For R_4 = R_{41}\cup R_{42} , system (1.4) has five equilibria E_0 (saddle), E_1 (stable node), E_{21} (unstable node), E_{22} (stable node or saddle-node) and E_{31} (saddle). Particularly, E_{22} is stable in the first quadrant. As shown in Figure 1(g), the qualitative properties of these five equilibria are given.

    For R_5 , system (1.4) possesses six equilibria E_0 , E_1 , E_{21} , E_{22} , E_{31} and E_{32} , which represent saddle, stable node, unstable node, saddle, saddle and stable node, respectively. Hence, the qualitative properties of these six equilibria are displayed by Figure 1(h).

    In this section, all possible bifurcations of system (1.4) will be found out. Moreover, the feasible conditions for the occurence of those bifurcations will be given.

    Theorem 2.5. System (1.4) undergoes a saddle-node bifurcation at equilibrium E_{33} when the parameters satisfy the restriction \alpha = \alpha_{SN} = \frac{(\delta+\beta\gamma)^2}{4\beta} along with the conditions 0 < \delta-\beta\gamma < 2\beta and \alpha > \delta+\delta\gamma-\beta-\beta\gamma as given in Theorem 2.1.

    Proof. Now we will verify the transversality condition for the occurrence of a saddle-node bifurcation at \alpha = \alpha_{SN} by utilizing the Sotomayor's theorem [36]. From Section 2.2, we have the two eigenvalues of J(E_{33}) are \lambda_1(E_{33}) < 0 and \lambda_2(E_{33}) = 0 . Denote V and W the eigenvectors corresponding to the eigenvalue \lambda_2(E_{33}) for the matrices J (E_{33}) and J (E_{33})^T , respectively. Simple computations yield

    \begin{equation*} V = \left(\begin{array}{c} v_1\\ v_2 \end{array}\right) = \left(\begin{array}{c} -1\\ 1 \end{array}\right)\ \text{and} \ W = \left(\begin{array}{c} w_1\\ w_2 \end{array}\right) = \left(\begin{array}{c} 0\\ 1 \end{array}\right). \end{equation*}

    Furthermore, we can obtain

    \begin{equation} F_{\alpha}(E_{33};\alpha_{SN}) = \left(\begin{array}{c} 0\\ -\frac{y}{\gamma+y} \end{array}\right)_{(E_{33};\alpha_{SN})} = \left(\begin{array}{c} 0\\ -\frac{\delta-\beta\gamma}{\delta+\beta\gamma} \end{array}\right) \end{equation} (2.26)

    and

    \begin{eqnarray} D^2F(E_{33};\alpha_{SN})(V, V)& = &\left(\begin{array}{c} \frac{\partial^2F_1}{\partial x^2}v_{1}^2+2\frac{\partial^2F_1}{\partial x\partial y}v_{1}v_{2} +\frac{\partial^2F_1}{\partial y^2}v_{2}^2 \\ \frac{\partial^2F_2}{\partial x^2}v_{1}^2+2\frac{\partial^2F_2}{\partial x\partial y}v_{1}v_{2} +\frac{\partial^2F_2}{\partial y^2}v_{2}^2 \end{array}\right)_{(E_{33}; \alpha_{SN})} = \left(\begin{array}{c} 0\\ -2\beta+\frac{2\alpha_{SN}\gamma}{(\gamma+y_3^*)^3} \end{array}\right). \end{eqnarray} (2.27)

    Obviously, when 0 < \delta-\beta\gamma < 2\beta , the vectors V and W satisfy the transversality conditions

    \begin{equation*} W^T F_{\alpha}(E_{33}; \alpha_{SN}) = -\frac{\delta-\beta\gamma}{\delta+\beta\gamma}\neq0 \end{equation*}

    and

    \begin{equation*} W^T\left[D^2 F(E_{33};\alpha_{SN})(V, V)\right] = -2\beta+\frac{2\alpha_{SN}\gamma}{(\gamma+y_3^*)^3} = \frac{2\beta(\beta\gamma-\delta)}{\delta+\beta\gamma}\neq0. \end{equation*}

    Hence, by Sotomayor's theorem, when \alpha = \alpha_{SN} , system (1.4) undergoes a saddle-node bifurcation at non-hyperbolic critical point E_{33} . The number of positive equilibria of system (1.4) changes from zero to two as \alpha passes from the right of \alpha = \alpha_{SN} to the left. Thus, the proof of Theorem 2.5 is completed.

    Theorem 2.6. System (1.4) undergoes a transcritical bifurcation at the boundary equilibrium E_{1} when the parameters satisfy the conditions \alpha = \alpha_{TC} = \delta\gamma and 0 < \delta-\beta\gamma < 2\beta .

    Proof. Now we also apply Sotomayor's theorem [36] to prove the transversality condition for the occurrence of transcritical bifurcation at E_{1} as \alpha = \alpha_{TC} . From Section 2.2, we know that \lambda_1(E_{1}) < 0 and \lambda_2(E_{1}) = 0 . Let V and W represent the two eigenvectors corresponding to the zero eigenvalue \lambda_2(E_{1}) of the matrices J (E_{1}) and J (E_{1})^T , respectively, then they are given by

    \begin{equation*} V = \left(\begin{array}{c} v_1\\ v_2 \end{array}\right) = \left(\begin{array}{c} -1\\ 1 \end{array}\right)\ \text{and} \ W = \left(\begin{array}{c} w_1\\ w_2 \end{array}\right) = \left(\begin{array}{c} 0\\ 1 \end{array}\right). \end{equation*}

    Furthermore, we can obtain

    \begin{equation} F_{\alpha}(E_{1};\alpha_{TC}) = \left(\begin{array}{c} 0\\ -\frac{y}{\gamma+y} \end{array}\right)_{(E_{1};\alpha_{TC})} = \left(\begin{array}{c} 0\\ 0 \end{array}\right), \end{equation} (2.28)
    \begin{equation} DF_{\alpha}(E_{1};\alpha_{TC})V = \left(\begin{array}{cc} 0&0\\ 0&-\frac{\gamma}{(\gamma+y)^2} \end{array}\right) \left(\begin{array}{c} -1\\ 1 \end{array}\right) _{(E_{1};\alpha_{TC})} = \left(\begin{array}{c} 0\\ -\frac{1}{\gamma} \end{array}\right), \end{equation} (2.29)

    and

    \begin{eqnarray} D^2F(E_{1};\alpha_{TC})(V, V)& = &\left(\begin{array}{c} \frac{\partial^2F_1}{\partial x^2}v_{1}^2+2\frac{\partial^2F_1}{\partial x\partial y}v_{1}v_{2} +\frac{\partial^2F_1}{\partial y^2}v_{2}^2\\ \frac{\partial^2F_2}{\partial x^2}v_{1}^2+2\frac{\partial^2F_2}{\partial x\partial y}v_{1}v_{2} +\frac{\partial^2F_2}{\partial y^2}v_{2}^2 \end{array}\right)_{(E_{1}; \alpha_{TC})} = \left(\begin{array}{c} 0\\ -2\beta+\frac{2\delta}{\gamma} \end{array}\right). \end{eqnarray}

    Clearly, the vectors V and W satisfy the transversality conditions

    \begin{equation*} W^T F_{\alpha}(E_{1}; \alpha_{TC}) = 0, \quad W^T \left[DF_{\alpha}(E_{1}; \alpha_{TC})V\right] = -\frac{1}{\gamma}\neq 0 \end{equation*}

    and

    \begin{equation*} W^T\left[D^2 F(E_{1};\alpha_{TC})(V, V)\right] = -2\beta+\frac{2\delta}{\gamma}\neq 0\ \ \text{for} \ 0 < \delta-\beta\gamma < 2\beta. \end{equation*}

    Therefore, by Sotomayor's theorem, if \delta\neq \beta\gamma , system (1.4) experiences a transcritical bifurcation at non-hyperbolic critical point E_{1} as the parameter \alpha varies through the bifurcation value \alpha = \alpha_{TC} .

    Thus, the proof of Theorem 2.6 is completed.

    In this subsection, we pay some attention to the global structure of the plane nonlinear dynamic system (1.4).

    For the sake of the research of the global dynamics for system (1.4), we have to investigate the qualitative properties of equilibria at infinity, which is important and useful to study the behavior of orbits when |x|+|y| \rightarrow \infty .

    Firstly, using Poincaré transformation of Chapter 5 in [35]:

    x = \frac{1}{z},\quad y = \frac{u}{z},\quad ds = \frac{dt}{z},

    system (1.4) can be transformed into

    \begin{equation} \left\{\begin{array}{l} \frac{du}{ds} = (1-\beta)u^2+(\delta-1)uz+u-\frac{\alpha uz^2}{u+\gamma z},\\ \frac{dz}{ds} = uz+z-z^2. \end{array}\right. \end{equation} (2.30)

    In the first quadrant of u - z plane, setting z = 0 , system (2.30) has one boundary equilibrium e\left(\frac{1}{\beta-1}, 0\right) if \beta > 1 and no boundary equilibrium if \beta \leq 1 on the nonnegative u -axis.

    Proceed to the next step, we apply the second type of Poincaré transformation:

    x = \frac{v}{z}, \quad y = \frac{1}{z}, \quad ds = \frac{dt}{z},

    system (1.4) becomes

    \begin{equation} \left\{\begin{array}{l} \frac{dv}{ds} = -v^2+(1-\delta)vz+(\beta-1)v+\frac{\alpha vz^2}{1+\gamma z},\\ \frac{dz}{ds} = -\delta z^2+\beta z+\frac{\alpha z^3}{1+\gamma z}. \end{array}\right. \end{equation} (2.31)

    In the nonnegative cone of v - z plane, there exist two boundary equilibria e_1(0, 0) and e_2(\beta-1, 0) if \beta > 1 and only one e_1(0, 0) if \beta \leq 1 for system (2.31) .

    In this paper, of concern is the global dynamics of system (1.4) when \beta > 1 . The case \beta\leq1 is similar, hence, it is omitted.

    Theorem 2.7. In system (2.30) , e\left(\frac{1}{\beta-1}, 0\right) is a saddle. In system (2.31) , e_1(0, 0) is an unstable node and e_2(\beta-1, 0) is a saddle.

    Proof. The Jacobian matrix at e\left(\frac{1}{\beta-1}, 0\right) is evaluated as follows:

    J(e) = \left(\begin{array}{cc} -1&\frac{\delta-1}{\beta-1}\\ 0&\frac{\beta}{\beta-1} \end{array}\right),

    obviously, which has two eigenvalues \lambda_1(e) = -1 < 0 and \lambda_2(e) = \frac{\beta}{\beta-1} > 0 . Hence, e is a saddle in system (2.30) .

    Similarly, the corresponding Jacobian matrices of system (2.31) evaluated at e_1 (0, 0) and e_2 (\beta-1, 0) are

    J(e_1) = \left(\begin{array}{cc} \beta-1&0\\ 0&\beta \end{array}\right) \ \ \text{and} \ \ J(e_2) = \left(\begin{array}{cc} 1-\beta&-(\delta-1)(\beta-1)\\ 0&\beta \end{array}\right).

    Clearly, e_1 is an unstable node and e_2 is a saddle in system (2.31) . This proof of Theorem 2.7 is completed.

    From the point of view of Poincaré transformation, we get

    \begin{eqnarray*} \begin{array}{l} x\triangleq\dfrac{1}{z} = +\infty, \ y\triangleq\dfrac{u}{z} = +\infty, \ x_1\triangleq\dfrac{v_1}{z_1} = 0,\\ y_1\triangleq\dfrac{1}{z_1} = +\infty,\ x_2\triangleq\dfrac{v_2}{z_2} = +\infty,\ y_2\triangleq\dfrac{1}{z_2} = +\infty. \end{array} \end{eqnarray*}

    Consequently, e and e_2 are equivalent to an infinite singular point I for system (1.4) , e_1 is equivalent to an infinite singular point I_1 for system (1.4) . By combining the Poincaré transformation of Chapter 5 in [35] and Theorem 2.7, we illustrate the dynamical behaviors near infinity of model (1.4) with Figure 2.

    Figure 2.  The dynamics of system (1.4) near infinity.

    We, here, for further research of the global structure of system (1.4), need to discuss the existence of closed orbits in phase space.

    Theorem 2.8. No closed orbit exists for model (1.4) in R_+^{2} .

    Proof. On the contrary, assume that model (1.4) exhibits a closed orbit in R_+^{2} . From the discussion in Theorem 2.1, we can deduce that all positive equilibria will lie on invariant lines y = \frac{\delta-\beta\gamma- \sqrt{\Delta}}{2\beta} or y = \frac{\delta-\beta\gamma+\sqrt{\Delta}}{2\beta} . On the basis of Theorem 4.6 of [35], in the interior of the closed orbit, system (1.4) must admit a positive equilibrium. As such, the closed orbit has two points of intersection with y = \frac{\delta-\beta\gamma- \sqrt{\Delta}}{2\beta} or y = \frac{\delta-\beta\gamma+\sqrt{\Delta}}{2\beta} , which is contrary to the existence and uniqueness of solutions. Therefore, there is no closed orbit for model (1.4). We end the proof of Theorem 2.8.

    System (1.4), according to the aforementioned Theorem 2.7, admits two equilibria I and I_1 at infinity, which stand for a saddle and an unstable node, respectively. A step further, we derive that model (1.4) exists no closed orbit in R_+^{2} from the above Theorem 2.8. It now follows that all possible cases of global phase portraits for model (1.4) can be given.

    For the purpose of simplicity, \xi_I and \omega(\xi_I) are utilized to refer the unstable manifold of I and the \omega -limit set of \xi_I in the nonnegative cone of R^{2} , respectively.

    For \left(\alpha, \beta, \gamma, \delta \right) \in R_1 , it is easy to be checked that \omega(\xi_I) is E_1 . See Figure 3(a) for the global phase portrait of model (1.4) related to the case R_1 .

    Figure 3.  The global phase portraits of system (1.4).

    For \left(\alpha, \beta, \gamma, \delta \right) \in R_2 , we can easily verify that \omega(\xi_I) is E_{22} in R_{21} and \omega(\xi_I) is E_{23} in R_{22} . See Figure 3(b), (c) for the global phase portraits of model (1.4) related to the cases R_{21} and R_{22} .

    For \left(\alpha, \beta, \gamma, \delta \right) \in R_3 , we analyze the global phase portraits of model (1.4) from the three subregions R_{31} , R_{32} and R_{33} , respectively. When \left(\alpha, \beta, \gamma, \delta \right) \in R_{31} , we can verify that \omega(\xi_I) is E_{32} . The global phase portraits of model (1.4) related to R_{31} are given by Figure 3(d), (e). When \left(\alpha, \beta, \gamma, \delta \right) \in R_{32} , \omega(\xi_I) is E_{22} . The global phase portrait of model (1.4) related to R_{32} is shown by Figure 3(f). When \left(\alpha, \beta, \gamma, \delta \right) \in R_{33} , it is clear that \omega(\xi_I) is E_{33} and the global phase portraits of model (1.4) in this region are shown in Figure 3(g), (h).

    For \left(\alpha, \beta, \gamma, \delta \right) \in R_4 , it is clear that \omega(\xi_I) is E_{22} . See Figure 3(i) for the global phase portrait of model (1.4) related to the case R_4 .

    For \left(\alpha, \beta, \gamma, \delta \right) \in R_5 , it is also clear that \omega(\xi_I) is E_{32} . And the global phase portraits of model (1.4) in R_5 are shown in Figure 3(j), (k).

    Now, we mainly consider the dynamic properties of all possible equilibria and bifurcation behaviors of model (1.1) . More, in R_+^{2} , we analyze the global structure of this model and illustrate our analysis with the global phase portraits.

    To facilitate this, system (1.1) takes the following form

    \begin{equation} \left\{\begin{array}{l} \frac{dx}{dt} = x(1-x-y),\\ \frac{dy}{dt} = y(\delta-\beta y). \end{array}\right. \end{equation} (3.1)

    On account of the dynamic properties of system (3.1) corresponding to system (1.1) , we study the dynamics of system (3.1) in the following.

    As it has been shown in [5], the existence and stability properties of equilibria of system (3.1) are clearly summarized in Table 2. Next, we divide (\delta, \beta) \in R_+^{2} into two regions as follows.

    \begin{aligned} G_1& = G_{11}\cup G_{12} = \left\lbrace (\delta,\beta) \in R_+^{2}: 0 < \beta < \delta \right\rbrace\cup\left\lbrace (\delta,\beta) \in R_+^{2}: \delta = \beta \right\rbrace;\\ G_2& = \left\lbrace (\delta,\beta) \in R_+^{2}: 0 < \delta < \beta \right\rbrace. \end{aligned}
    Table 2.  Local dynamical properties of equilibria.
    Equilibrium Existence conditions Type
    E_0(0,0) (always exists) unstable node
    E_1(1,0) (always exists) saddle
    E_{2}\left(0,\frac{\delta}{\beta}\right) 0<\delta<\beta saddle
    \delta =\beta non-hyperbolic (stable in R_+^{2} )
    0<\beta<\delta stable node
    E_{3}\left(1-\frac{\delta}{\beta}, \frac{\delta}{\beta}\right) 0<\delta<\beta stable node

     | Show Table
    DownLoad: CSV

    Consider (\delta, \beta) \in G_1 , system (3.1) has three equilibria E_0 , E_1 and E_2 . Specifically, E_0 and E_1 represent an unstable node and a saddle. E_2 is a stable node in G_{11} and non-hyperbolic in G_{12} , which is stable in the first quadrant. See Figure 4(a), the qualitative properties of these three equilibria are illustrated.

    Figure 4.  The qualitative properties of the equilibria for G_{1} and G_{2} .

    Consider (\delta, \beta) \in G_2 , system (3.1) admits four equilibria E_0 , E_1 , E_2 and E_3 , which are unstable node, saddle, saddle and stable node, respectively. See Figure 4(b), the qualitative properties of these four equilibria are illustrated.

    Here, we will analyze some of all the possible bifurcation scenarios for model (3.1) . According to the previous methods applied in Section 2.3, a heuristic discussion similar to the one used by Theorem 2.6 can easily get the conditions for a transcritical bifurcation. Therefore, the following theorem can be directly obtained.

    Theorem 3.1 System (3.1) undergoes a transcritical bifurcation at E_2 when the parameters satisfy the condition \delta = \beta .

    In order to investigate the global structure of system (3.1) , the methods proposed by Section 2.4 can be extended. By applying Poincaré transformation and analysis of closed orbit, Figure 5(a) describes the existence and stability of the singular points at infinity, as well as all the boundary equilibria. In addition, Figure 5(b)(d) describes minutely the global phase portraits in R_+^{2} similarly.

    Figure 5.  (a) The dynamics of (3.1) near infinity; (b) The global phase portrait of (3.1) in G_{1} ; (c) The global phase portrait of (3.1) in G_{1} ; (d) The global phase portrait of (3.1) in G_{2} .

    Some numerical examples, in this section, are proposed so as to check the obtained parameter conditions and theoretical results of systems (1.4) and (3.1) . Further, we are interested to show the role of harvesting on the local dynamical properties.

    Example 4.1. We consider parameter values as below: \alpha = 2, \beta = 1.2, \gamma = 0.8, \delta = 2.5. Simple calculations lead to \alpha = \alpha^{**} , \delta-\beta\gamma \geq \beta and \delta > \beta , which means both systems (1.4) and (3.1) have three boundary equilibria. The numerical phase portraits related to this case are shown in Figures 6(a) and 7(a). The impact of harvesting is shown by Figure 8.

    Figure 6.  The numerical phase portraits of system (1.4): (a) \alpha = 2, \beta = 1.2, \gamma = 0.8, \delta = 2.5; (b) \alpha = 1.85, \beta = 0.3, \gamma = 2.5, \delta = 0.8; (c) \alpha = 0.8, \beta = 2.5, \gamma = 0.4, \delta = 2.
    Figure 7.  The numerical phase portraits of system (3.1) : (a) \beta = 1.2, \delta = 2.5; (b) \beta = 0.3, \delta = 0.8; (c) \beta = 2.5, \delta = 2.
    Figure 8.  The impact of Michaelis-Menten type harvesting on the second species.

    Example 4.2. Some parameter values are taken \alpha = 1.85, \beta = 0.3, \gamma = 2.5 and \delta = 0.8. In this case, parameters satisfy the conditions 0 < \alpha < \alpha^{**} and \alpha > \delta+\delta\gamma-\beta-\beta\gamma . Consequently, system (1.4) has a positive equilibrium (global asymptotically stable) and three boundary equilibria. From \delta > \beta , we can effortlessly observe there exists no positive equilibrium for model (3.1) . See Figures 6(b) and 7(b), the numerical phase portraits corresponding to this situation are presented. The impact of harvesting is illustrated with curves in Figure 9.

    Figure 9.  The impact of Michaelis-Menten type harvesting on the second species.

    Example 4.3. We select parameter values as follows: \alpha = 0.8, \beta = 2.5, \gamma = 0.4, \delta = 2. For these parameters, we derive \alpha = \alpha^{**} and 0 < \delta-\beta\gamma < 2\beta . Therefore, system (1.4) possesses the same types of equilibria as the above Example 4.2. Whereas, there is a positive equilibrium (global asymptotically stable) in system (3.1) for \delta < \beta . See Figures 6(c) and 7(c), the corresponding numerical phase portraits are presented. The impact of harvesting is illustrated with curves in Figure 10.

    Figure 10.  The impact of Michaelis-Menten type harvesting on the second species.

    It can be seen that the harvesting effect has a significant role on the population densities. From a biological point of view, the permanence and extinction of species are influenced to differential extent by the harvesting effect on the second species, for instance, greatly slowing the extinction of the first species (Figure 8) or guaranteeing the permanence of the system by preserving the first species from extinction (Figure 9). In addition, both species need much more time to reach their stable coexistence state due to the harvesting effect, which is shown in Figure 10.

    In this article, by combining local and global dynamical analysis, we have investigated the dynamics of the amensalism system with Michaelis-Menten type harvesting for the second species. In order to further explore the influence of harvesting effect, a complete qualitative analysis of the system with no harvesting is also performed. We could show some differences for the model (1.4) with harvesting on the second species and the system (3.1) with no harvesting.

    1) When harvesting is present in the system, it has shown that model (1.4) has more different types of equilibria. System (3.1) has at most four equilibria including one interior point in {R}^{2}_+ and the unique interior point (if it exists) of system (3.1) is globally stable. However, when the Michaelis-Menten type harvesting is on the second species, we shown that the model (1.4) has at most six equilibria including two interior points in {R}^{2}_+ and the interior point E_{31} is a saddle.

    2) The complex existence of equilibria leads to more bifurcation behaviors of model (1.4). Two kinds of bifurcation, under some parameter restrictions, saddle-node bifurcation and transcritical bifurcation will occur for system (1.4), while there exhibits only one saddle-node bifurcation for the system with no harvesting.

    3) More types of equilibria and more bifurcation behaviors can induce potentially dramatic changes to the dynamics of the system. By the classifications of global phase portraits of model (1.4), we find that more complex dynamics occur for the appearance of harvesting on the second species. Such as, for model (1.4) with harvesting, the first species survives permanently rather than extinction or both species take a lot longer to approach the coexistence state.

    These results reveal that the dynamical properties of system (1.4) get more complicated and richer compared to the system with no harvesting. Furthermore, it would also be interesting to study system (3.1) with both the first species and the second species with harvesting terms since we usually harvest, or would like to harvest, both populations.

    The first author was supported by the National Natural Science Foundation of China (No.12001503) and the third author was supported by the Project of Beijing Municipal Commission of Education (KM 202110015001).

    The authors declare there is no conflicts of interest.

    [1] Gumeni S, Trougakos IP (2016) Cross talk of proteostasis and mitostasis in cellular homeodynamics, ageing, and disease. Oxidative Medicine and Cellular Longevity 2016: 4587691.
    [2] Ruegsegger C, Saxena S (2016) Proteostasis impairment in ALS. Brain Res S0006-8993: 30161–30165.
    [3] Pluquet O, Pourtier A, Abbadie C (2015) The unfolded protein response and cellular senescence. A review in the theme: cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. Am J Physiol Cell Physiol 308: C415–C425.
    [4] Klein ME, Monday H, Jordan BA (2016) Proteostasis and RNA binding proteins in synaptic plasticity and in the pathogenesis of neuropsychiatric disorders. Neural Plast 2016: 3857934.
    [5] Nakada C, Ritchie K, Oba Y, et al. (2003) Accumulation of anchored proteins forms membrane diffusion barriers during neuronal polarization. Nat Cell Biol 5: 626–632. doi: 10.1038/ncb1009
    [6] Guillery RW (2005) Observations of synaptic structures: origins of the neuron doctrine and its current status. Philos Trans R Soc Lond B Biol Sci 360: 1281–1307. doi: 10.1098/rstb.2003.1459
    [7] Citri A, Malenka RC (2008) Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33: 18–41. doi: 10.1038/sj.npp.1301559
    [8] Kessels HW, Malinow R (2009) Synaptic AMPA receptor plasticity and behavior. Neuron 61: 340–350. doi: 10.1016/j.neuron.2009.01.015
    [9] Hardingham N, Dachtler J, Fox K (2013) The role of nitric oxide in pre-synaptic plasticity and homeostasis. Front Cell Neurosci 7: 190.
    [10] Hashimotodani Y, Ohno-Shosaku T, Kano M (2007) Endocannabinoids and synaptic function in the CNS. Neuroscientist 13: 127–137. doi: 10.1177/1073858406296716
    [11] Casadio A, Martin KC, Giustetto M, et al. (1999) A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 99: 221–237. doi: 10.1016/S0092-8674(00)81653-0
    [12] Huber KM,Kayser MS, Bear MF (2000) Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288: 1254–1256.
    [13] Bradshaw KD, Emptage NJ, Bliss TV (2003) A role for dendritic protein synthesis in hippocampal late LTP. Eur J Neurosci 18: 3150–3152.
    [14] Yin HH, Davis MI, Ronesi JA, et al. (2006) The role of protein synthesis in striatal long-term depression. J Neurosci 26: 11811–11820. doi: 10.1523/JNEUROSCI.3196-06.2006
    [15] Zhang Y, Nicholatos J, Dreier JR, et al. (2014) Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 513: 440–443. doi: 10.1038/nature13492
    [16] Louros SR, Osterweil EK (2016) Perturbed proteostasis in autism spectrum disorders. J Neurochem 139: 1081–1092. doi: 10.1111/jnc.13723
    [17] American Psychiatric Association, (2013) Diagnostic and Statistical Manual of Mental Disorders: DSM-5, Arlington, Virginia: USA American Psychiatric Association.
    [18] de la Torre-Ubieta L, Won H, Stein JL, et al. (2016) Advancing the understanding of autism disease mechanisms through genetics. Nat Med 22: 345–361.
    [19] Geschwind DH, State MW (2015) Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol 14: 1109–1120.
    [20] Jaworski J, Sheng M (2006) The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol 34: 205–219. doi: 10.1385/MN:34:3:205
    [21] Bockaert J, Marin P (2015) mTOR in brain physiology and pathologies. Physiol Rev 95: 1157–1187. doi: 10.1152/physrev.00038.2014
    [22] Bramham CR, Wells DG (2007) Dendritic mRNA: transport, translation and function. Nat Rev Neurosci 8: 776–789.
    [23] Wang DO, Kim SM, Zhao Y, et al. (2009) Synapse- and stimulus-specific local translation during long-term neuronal plasticity. Science 324: 1536–1540. doi: 10.1126/science.1173205
    [24] Andreassi C, Riccio A (2009)To localize or not to localize: mRNA fate is in 3'UTRends. Trends Cell Biol 19: 465–474.
    [25] Besse F, Ephrussi A (2008) Translational control of localized mRNAs: restricting protein synthesis in space and time. Nat Rev Mol Cell Biol 9: 971–980.
    [26] Redondo RL, Morris R (2011) Making memories last: the synaptic tagging and capture hypothesis. Nat Rev Neurosci 12: 17–30. doi: 10.1038/nrn2963
    [27] Richter JD, Klann E (2009) Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev 23: 1–11. doi: 10.1101/gad.1735809
    [28] Thomas MG, Pascual ML, Maschi D, et al. (2014) Synaptic control of local translation: the plot thickens with new characters. Cell Mol Life Sci 71: 2219–2239. doi: 10.1007/s00018-013-1506-y
    [29] Doyle M, Kiebler MA (2011) Mechanisms of dendritic mRNA transport and its role in synaptic tagging. EMBO J 30: 3540–3552. doi: 10.1038/emboj.2011.278
    [30] Mayford M, Baranes D, Podsypanina K, et al. (1996) The 3'-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites. Proc Natl Acad Sci USA 93: 13250–13255. doi: 10.1073/pnas.93.23.13250
    [31] Kislauskis EH, Li Z, Singer RH, et al. (1993) Isoform-specific 3'-untranslated sequences sort alpha-cardiac and beta-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J Cell Biol 123: 165–172. doi: 10.1083/jcb.123.1.165
    [32] Blichenberg A, Schwanke B, Rehbein M, et al. (1999) Identification of a cis-acting dendritic targeting element in MAP2 mRNAs. J Neurosci 19: 8818–8829.
    [33] Kobayashi H, Yamamoto S, Maruo T, et al. (2005) Identification of a cis-acting element required for dendritic targeting of activity-regulated cytoskeleton-associated protein mRNA. Eur J Neurosci 22: 2977–2984. doi: 10.1111/j.1460-9568.2005.04508.x
    [34] An JJ, Gharami K, Liao GY, et al. (2008) Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134: 175–187. doi: 10.1016/j.cell.2008.05.045
    [35] Glanzer J, Miyashiro KY, Sul JY, et al. (2005) RNA splicing capability of live neuronal dendrites. Proc Natl Acad Sci USA 102: 16859–16864. doi: 10.1073/pnas.0503783102
    [36] Chawla G, Lin CH, Han A, et al. (2009) Sam68 regulates a set of alternatively spliced exons during neurogenesis. Mol Cell Biol 29: 201–213. doi: 10.1128/MCB.01349-08
    [37] Matter N, Herrlich P, König H (2002) Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420: 691–695. doi: 10.1038/nature01153
    [38] Khaladkar M, Buckley PT, Lee MT, et al. (2013) Subcellular RNA sequencing reveals broad presence of cytoplasmic intron-sequence retaining transcripts in mouse and rat neurons. PLoS One 8: 1–13.
    [39] Buckley PT, Lee MT, Sul JY, et al. (2011) Cytoplasmic intron sequence-retaining transcripts can be dendritically targeted via ID element retrotransposons. Neuron 69: 877–884.
    [40] Buchan JR (2014) mRNP granules. Assembly, function, and connections with disease. RNA Biol 11: 1019–1030.
    [41] Fritzsche R, Karra D, Bennett KL, et al. (2013) Interactome of two diverse RNA granules links mRNA localization to translational repression in neurons. Cell Rep 5: 1749–1762.
    [42] Ivanov PA, Chudinova EM, Nadezhdina ES (2003) Disruption of microtubules inhibits cytoplasmic ribonucleoprotein stress granule formation. Exp Cell Res 290: 227–233. doi: 10.1016/S0014-4827(03)00290-8
    [43] Hirokawa N (2006) mRNA transport in dendrites: RNA granules, motors, and tracks. J Neurosci 26: 7139–7142. doi: 10.1523/JNEUROSCI.1821-06.2006
    [44] Martin KC, Ephrussi A (2009) mRNA localization: gene expression in the spatial dimension. Cell 136: 719–730. doi: 10.1016/j.cell.2009.01.044
    [45] Kapeli K, Yeo GW (2012) Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases. Front Neurosci 6: 144.
    [46] Laggerbauer B, Ostareck D, Keidel EM, et al. (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10: 329–338. doi: 10.1093/hmg/10.4.329
    [47] Hüttelmaier S, Zenklusen D, Lederer M, et al. (2005) Spatial regulation of β-actin translation by Src-dependent phosphorylation of ZBP1. Nature 438: 512–515.
    [48] Darnell JC, Richter JD (2012) Cytoplasmic RNA-binding proteins and the control of complex brain function. Cold Spring Harb Perspect Biol 4: a012344.
    [49] Klein ME, Younts TJ, Castillo PE, et al. (2013) RNA-binding protein Sam68 controls synapse number and local β-actin mRNA metabolism in dendrites. Proc Natl Acad Sci USA 110: 3125–3130. doi: 10.1073/pnas.1209811110
    [50] Grange J, Belly A, Dupas S, et al. (2009) Specific interaction between Sam68 and neuronal mRNAs: implication for the activity-dependent biosynthesis of elongation factor eEF1A. J Neurosci Res 87: 12–25.
    [51] Eom T, Antar LN, Singer RH, et al. (2003) Localization of a beta-actin messenger ribonucleoprotein complex with zipcode-binding protein modulates the density of dendritic filopodia and filopodial synapses. J Neurosci 23: 10433–10444.
    [52] Itoh M, Haga I, Li QH, et al. (2002) Identification of cellular mRNA targets for RNA-binding protein Sam68. Nucleic Acids Res 30: 5452–5464. doi: 10.1093/nar/gkf673
    [53] Jung MY, Lorenz L, Richter JD (2006) Translational control by neuroguidin, a eukaryotic initiation factor 4E and CPEB binding protein. Mol Cell Biol 26: 4277–4287. doi: 10.1128/MCB.02470-05
    [54] Richter JD, Sonenberg N (2005) Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433: 477–480. doi: 10.1038/nature03205
    [55] Ivshina M, Lasko P, Richter JD (2014) Cytoplasmic polyadenylation element binding proteins in development, health, and disease. Annu Rev Cell Dev Biol 30: 393–415. doi: 10.1146/annurev-cellbio-101011-155831
    [56] Huang YS, Jung MY, Sarkissian M, et al. (2002) N-methyl-D-aspartate receptor signaling results in Aurora kinase-catalyzed CPEB phosphorylation and alpha CaMKII mRNA polyadenylation at synapses. EMBO J 21: 2139–2148. doi: 10.1093/emboj/21.9.2139
    [57] Wang CF, Huang YS (2012) Calpain 2 activated through N-methyl-D-aspartic acid receptor signaling cleaves CPEB3 and abrogates CPEB3-repressed translation in neurons. Mol Cell Biol 32: 3321–3332. doi: 10.1128/MCB.00296-12
    [58] Siomi H, Siomi MC, Nussbaum RL, et al. (1993) The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74: 291–298. doi: 10.1016/0092-8674(93)90420-U
    [59] Verkerk AJ, Pieretti M, Sutcliffe JS, et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65: 905–914. doi: 10.1016/0092-8674(91)90397-H
    [60] Tsuboi D, Kuroda K, Tanaka M, et al. (2015) Disrupted-in-schizophrenia 1 regulates transport of ITPR1 mRNA for synaptic plasticity. Nat Neurosc 18: 698–707.
    [61] Cohen TJ, Lee VM, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17: 659–667.
    [62] Koyama A, Sugai A, Kato T, et al. (2016) Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res 44: 5820–5836. doi: 10.1093/nar/gkw499
    [63] Udagawa T, Farny NG, Jakovcevski M, et al. (2013) Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology. Nat Med 19: 1473–1477. doi: 10.1038/nm.3353
    [64] Iacoangeli A, Tiedge H (2013) Translational control at the synapse: role of RNA regulators. Trends Biochem Sci 38: 47–55. doi: 10.1016/j.tibs.2012.11.001
    [65] Santini E, Huynh TN, Klann E (2014) Mechanisms of translation control underlying long-lasting synaptic plasticity and the consolidation of long-term memory. Prog Mol Biol Transl Sci 122: 131–167. doi: 10.1016/B978-0-12-420170-5.00005-2
    [66] Sonenberg N, Hinnebusch AG (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136: 731–745. doi: 10.1016/j.cell.2009.01.042
    [67] Thoreen CC (2013) Many roads from mTOR to eIF4F. Biochem Soc Trans 41: 913–916. doi: 10.1042/BST20130082
    [68] Pyronnet S (2000) Phosphorylation of the capbinding protein eIF4E by the MAPK-activated protein kinase Mnk1. Biochem Pharmacol 60: 1237–1243. doi: 10.1016/S0006-2952(00)00429-9
    [69] Panja D, Dagyte G, Bidinosti M, et al. (2009) Novel translational control in Arc-dependent long term potentiation consolidation in vivo. J Biol Chem 284: 31498–31511. doi: 10.1074/jbc.M109.056077
    [70] Tang SJ, Reis G, Kang H, et al. (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 99: 467–472. doi: 10.1073/pnas.012605299
    [71] Vilchez D, Saez I, Dillin A (2014) The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5: 5659. doi: 10.1038/ncomms6659
    [72] Yi JJ, Ehlers MD (2005) Ubiquitin and protein turnover in synapse function. Neuron 47: 629–632. doi: 10.1016/j.neuron.2005.07.008
    [73] Hamilton AM, Zito K (2013) Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis. Neural Plast 2013: 196848.
    [74] Bingol B, Schuman EM (2005) Synaptic protein degradation by the ubiquitin proteasome system. Curr Opin Neurobiol 15: 536–541.
    [75] Ravid T, Hochstrasser M (2008) Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol 9: 679–690. doi: 10.1038/nrm2468
    [76] Hegde AN (2010) The ubiquitin-proteasome pathway and synaptic plasticity. Learn Mem 17: 314–327. doi: 10.1101/lm.1504010
    [77] Bingol B, Sheng M (2011) Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease. Neuron 69: 22–32. doi: 10.1016/j.neuron.2010.11.006
    [78] Bingol B, Schuman EM (2006) Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 441: 1144–1148. doi: 10.1038/nature04769
    [79] Hegde AN (2016) Proteolysis, synaptic plasticity and memory. Neurobiol Learn Mem S1074-7427: 30178–30172.
    [80] Li Q, Korte M, Sajikumar S (2016) Ubiquitin-proteasome system inhibition promotes long-term depression and synaptic tagging/capture. Cereb Cortex 26: 2541–2548. doi: 10.1093/cercor/bhv084
    [81] Ciechanover A, Kwon YT (2015) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. ExpMol Med 47: e147.
    [82] Tarpey PS, Raymond FL, O'Meara S, et al. (2007) Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pescavus, and tremor. Am J Hum Genet 80: 345–352. doi: 10.1086/511134
    [83] Dong C, Bach SV, Haynes KA, et al. (2014) Proteasome modulates positive and negative translational regulators in long-term synaptic plasticity. J Neurosci 34: 3171–3182. doi: 10.1523/JNEUROSCI.3291-13.2014
    [84] Johnson CW, Melia TJ, Yamamoto A (2012) Modulating macroautophagy: a neuronal perspective. Future Med Chem 4: 1715–1731. doi: 10.4155/fmc.12.112
    [85] Komatsu M, Waguri S, Chiba T, et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006 441: 880–884.
    [86] Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147: 728–741. doi: 10.1016/j.cell.2011.10.026
    [87] Hu Z, Yang B, Mo X, et al. (2015) Mechanism and regulation of autophagy and its role in neuronal diseases. Mol Neurobiol 52: 1190–1209. doi: 10.1007/s12035-014-8921-4
    [88] Tang G, Gudsnuk K, Kuo SH, et al. (2014) Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 83: 1131–1143. doi: 10.1016/j.neuron.2014.07.040
    [89] Penzes P, Cahill ME, Jones KA, et al. (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14: 285–293. doi: 10.1038/nn.2741
    [90] Riccomagno MM, Kolodkin AL (2015) Sculpting neural circuits by axon and dendrite pruning. Annu Rev Cell Dev Biol 31: 779–805. doi: 10.1146/annurev-cellbio-100913-013038
    [91] Jung CH, Ro SH, Cao J, et al. (2010) mTOR regulation of autophagy. FEBS Lett 584: 1287–1295. doi: 10.1016/j.febslet.2010.01.017
    [92] Lipton JO, Sahin M (2014) The neurology of mTOR. Neuron 84: 275–291. doi: 10.1016/j.neuron.2014.09.034
    [93] Roohi A, Hojjat-Farsangi M (2016) Recent Advances in targeting mTORsignaling pathway using small molecule inhibitors. J Drug Target 15: 1–37.
    [94] Jacinto E, Loewith R, Schmidt A, et al. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6: 1122–1128. doi: 10.1038/ncb1183
    [95] Gaubitz C, Prouteau M, Kusmider B, et al. (2016) TORC2 structure and function. Trends Biochem Sci 41: 532–545. doi: 10.1016/j.tibs.2016.04.001
    [96] Huang W, Zhu PJ, Zhang S, et al. (2013) mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat Neurosci 16: 441–448. doi: 10.1038/nn.3351
    [97] Johnson JL, Huang W, Roman G, et al. (2015) TORC2: a novel target for treating age-associated memory impairment. Sci Rep 5: 15193. doi: 10.1038/srep15193
    [98] Lenz G, Avruch J (2005) Glutamatergic regulation of the p70S6 kinase in primary mouse neurons. J Biol Chem 280: 38121–38124. doi: 10.1074/jbc.C500363200
    [99] Takei N, Inamura N, Kawamura M, et al. (2004) Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci 24: 9760–9769. doi: 10.1523/JNEUROSCI.1427-04.2004
    [100] Lee CC, Huang CC, Wu MY, et al. (2005) Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J Biol Chem 280: 18543–18550. doi: 10.1074/jbc.M414112200
    [101] Costa-Mattioli M, Monteggia LM (2013) mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 16: 1537–1543. doi: 10.1038/nn.3546
    [102] Sosanya NM, Cacheaux LP, Workman ER, et al. (2015) Mammalian target of rapamycin (mTOR) tagging promotes dendritic branch variability through the capture of Ca2+/calmodulin-dependent protein kinase II α (CaMKIIα) mRNAs by the RNA-binding protein HuD. J Biol Chem 290: 16357–16371. doi: 10.1074/jbc.M114.599399
    [103] Meyuhas O, Kahan T (2015) The race to decipher the top secrets of TOP mRNAs. Biochim Biophys Acta 1849: 801–811. doi: 10.1016/j.bbagrm.2014.08.015
    [104] Ehninger D, Han S, Shilyansky C, et al. (2008) Reversal of learning deficits in a Tsc2+/– mouse model of tuberous sclerosis. Nat Med 14: 843–848.
    [105] Kwon CH, Luikart BW, Powell CM, et al. (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377–388. doi: 10.1016/j.neuron.2006.03.023
    [106] Hoeffer CA, Sanchez E, Hagerman RJ, et al. (2012) Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav 11: 332–341. doi: 10.1111/j.1601-183X.2012.00768.x
    [107] Sharma A, Hoeffer CA, Takayasu Y, et al. (2010) Deregulation of mTOR signaling in fragile X syndrome. J Neurosci 30: 694–702.
    [108] Ricciardi S, Boggio EM, Grosso S, et al. (2011) Reduced AKT/mTOR signaling and protein synthesis deregulation in a Rett syndrome animal model. Hum Mol Genet 20: 1182–1196. doi: 10.1093/hmg/ddq563
    [109] Ramocki MB, Tavyev YJ, Peters SU (2010) The MECP2 duplication syndrome. Am J Med Genet A 152A: 1079–1088. doi: 10.1002/ajmg.a.33184
    [110] Sun J, Liu Y, Moreno S, et al. (2015) Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function. J Neurosci 35: 4706–4718. doi: 10.1523/JNEUROSCI.4276-14.2015
    [111] Stornetta RL, Zhu JJ (2011) Ras and Rap signaling in synaptic plasticity and mental disorders. Neuroscientist 17: 54–78. doi: 10.1177/1073858410365562
    [112] Phillips M, Pozzo-Miller L (2015) Dendritic spine dysgenesis in autism related disorders. Neurosci Lett 601: 30–40. doi: 10.1016/j.neulet.2015.01.011
    [113] Huber KM, Klann E, Costa-Mattioli M, et al. (2015) Deregulation of mammalian target of rapamycin signaling in mouse models of autism. J Neurosci 35: 13836–13842.
    [114] Kelleher RJ III, Bear MF (2008) The autistic neuron: troubled translation? Cell 135: 401–406. doi: 10.1016/j.cell.2008.10.017
    [115] Zhou J, Blundell J, Ogawa S, et al. (2009) Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 29: 1773–1783. doi: 10.1523/JNEUROSCI.5685-08.2009
    [116] Busquets-Garcia A, Gomis-González M, Guegan T, et al. (2013) Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med 19: 603–607. doi: 10.1038/nm.3127
    [117] Sun J, Liu Y, Tran J, et al. (2016) mTORC1-S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice. Cell Mol Life Sci 73: 4303–4314. doi: 10.1007/s00018-016-2269-z
    [118] van Slegtenhorst M, de Hoogt R, Hermans C, et al. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805–808. doi: 10.1126/science.277.5327.805
    [119] European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification andcharacterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305–1315.
    [120] Kwiatkowski DJ, Manning BD (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 14 Spec No. 2: R251–R258.
    [121] Hwang SK, Lee JH, Yang JE, et al. (2016) Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation. Mol Brain 9: 56. doi: 10.1186/s13041-016-0222-6
    [122] Meikle L, Pollizzi K, Egnor A, et al. (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28: 5422–5432. doi: 10.1523/JNEUROSCI.0955-08.2008
    [123] Sato A, Kasai S, Kobayashi T, et al. (2012) Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun 3: 1292.
    [124] Williams VC, Lucas J, Babcock MA, et al., (2009) Neurofibromatosis type 1 revisited. Pediatrics 123: 124–133. doi: 10.1542/peds.2007-3204
    [125] Garg S, Plasschaert E, Descheemaeker MJ, et al. (2015) Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord 45: 1649–1657.
    [126] Plasschaert E, Descheemaeker MJ, Van Eylen L, et al. (2015) Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. Am J Med Genet B Neuropsychiatr Genet 168B: 72–80.
    [127] Basu TN, Gutmann DH, Fletcher JA, et al. (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713–715.
    [128] Guilding C, McNair K, Stone TW, et al. (2007) Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. Eur J Neurosci 25: 99–105. doi: 10.1111/j.1460-9568.2006.05238.x
    [129] Wang Y, Kim E, Wang X, et al. (2012) ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell 150: 816–830. doi: 10.1016/j.cell.2012.06.034
    [130] Acosta MT, Kardel PG, Walsh KS, et al. (2011) Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. PediatrNeurol 45: 241–245.
    [131] Li W, Cui Y, Kushner SA, et al. (2005) The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 15: 1961–1967. doi: 10.1016/j.cub.2005.09.043
    [132] Osterweil EK, Chuang SC, Chubykin AA, et al. (2013) Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron 77: 243–250. doi: 10.1016/j.neuron.2012.01.034
    [133] Waite KA, Eng C (2002) Protean PTEN: form and function. Am J Hum Genet 70: 829–844.
    [134] Butler MG, Dasouki MJ, Zhou XP, et al. (2005) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42: 318–321. doi: 10.1136/jmg.2004.024646
    [135] Goffin A, Hoefsloot LH, Bosgoed E, et al. (2001) PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 105: 521–524. doi: 10.1002/ajmg.1477
    [136] Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375–13378.
    [137] Penagarikano O, Mulle JG, Warren ST (2007) The pathophysiology of fragile X syndrome. Annu Rev Genomics Hum Genet 8: 109–129. doi: 10.1146/annurev.genom.8.080706.092249
    [138] Brown V, Jin P, Ceman S, et al. (2001) Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107: 477–487.
    [139] Darnell JC, Van Driesche SJ, Zhang C, et al. (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146: 247–261.
    [140] Gross C, Nakamoto M, Yao X, et al. (2010) Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci 30: 10624–10638. doi: 10.1523/JNEUROSCI.0402-10.2010
    [141] Gross C, Chang CW, Kelly SM, et al (2015) Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome. Cell Rep 11: 727–736. doi: 10.1016/j.celrep.2015.03.060
    [142] Darnell JC, Klann E (2013) The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci 16: 1530–1536.
    [143] Richter JD, Bassell GJ, Klann E (2015) Deregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci 16: 595–605. doi: 10.1038/nrn4001
    [144] Osterweil EK, Krueger DD, Reinhold K, et al. (2010) Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci 30: 15616–15627. doi: 10.1523/JNEUROSCI.3888-10.2010
    [145] Tsai NP, Wilkerson JR, Guo W, et al. (2012) Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell 151: 1581–1594. doi: 10.1016/j.cell.2012.11.040
    [146] Busquets-Garcia A, Maldonado R, Ozaita A (2014) New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model. Int J Biochem Cell Biol 53: 121–126. doi: 10.1016/j.biocel.2014.05.004
    [147] Berry-Kravis E, Des Portes V, Hagerman R, et al. (2016) Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med 8: 321ra5.
    [148] Shepherd GM, Katz DM (2011) Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met. Curr Opin Neurobiol 21: 827–833. doi: 10.1016/j.conb.2011.06.006
    [149] Lombardi LM, Baker SA, Zoghbi HY (2015) MECP2 disorders: from the clinic to mice and back. J Clin Invest 125: 2914–2923. doi: 10.1172/JCI78167
    [150] Chahrour M, Jung SY, Shaw C, et al. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224–1229. doi: 10.1126/science.1153252
    [151] Jiang M, Ash RT, Baker SA, et al. (2013) Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome. J Neurosci 33: 19518–19533. doi: 10.1523/JNEUROSCI.1745-13.2013
    [152] Buiting K, Williams C, Horsthemke B (2016) Angelman syndrome-insights into a rare neurogenetic disorder. Nat Rev Neurol 12: 584–593. doi: 10.1038/nrneurol.2016.133
    [153] Kishino T, Lalande M, Wagstaff J (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15: 70–73. doi: 10.1038/ng0197-70
    [154] Vu TH, Hoffman AR (1997) Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet 17: 12–13. doi: 10.1038/ng0997-12
    [155] Reiter LT, Seagroves TN, Bowers M, et al. (2006) Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase. Hum Mol Genet 15: 2825–2835. doi: 10.1093/hmg/ddl225
    [156] Jiang YH, Armstrong D, Albrecht U, et al. (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21: 799–811. doi: 10.1016/S0896-6273(00)80596-6
    [157] Mishra A, Godavarthi SK, Jana NR (2009) UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27. Neurobiol Dis 36: 26–34. doi: 10.1016/j.nbd.2009.06.010
    [158] Kumar S, Talis AL, Howley PM (1999) Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J Biol Chem 274: 18785–18792. doi: 10.1074/jbc.274.26.18785
    [159] Greer PL, Hanayama R, Bloodgood BL, et al. (2010) The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140: 704–716. doi: 10.1016/j.cell.2010.01.026
    [160] Margolis SS, Salogiannis J, Lipton DM, et al. (2010) EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 143: 442–455. doi: 10.1016/j.cell.2010.09.038
    [161] Jay V, Becker LE, Chan FW, et al. (1991) Puppet-like syndrome of Angelman: a pathologic and neurochemical study. Neurology 41: 416–422. doi: 10.1212/WNL.41.3.416
    [162] Hethorn WR, Ciarlone SL, Filonova I, et al. (2015) Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome. Eur J Neurosci 41: 1372–1380. doi: 10.1111/ejn.12893
    [163] Krishnan A, Zhang R, Yao V, et al. (2016) Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nat Neurosci 19: 1454–1462. doi: 10.1038/nn.4353
    [164] Kilpinen H, Ylisaukko-Oja T, Hennah W, et al. (2008) Association of DISC1 with autism and Asperger syndrome. Mol Psychiatry 13: 187–196. doi: 10.1038/sj.mp.4002031
    [165] Thomson PA, Parla JS, McRae AF, et al. (2014) 708 Common and 2010 rare DISC1 locus variants identified in 1542 subjects: analysis for association with psychiatric disorder and cognitive traits. Mol Psychiatry 19: 668–675. doi: 10.1038/mp.2013.68
    [166] Iossifov I, O'Roak BJ, Sanders SJ, et al. (2014) The contribution of de novo coding mutations to autism spectrum disorder. Nature 515: 216–221. doi: 10.1038/nature13908
    [167] Krumm N, Turner TN, Baker C, et al. (2015) Excess of rare, inherited truncating mutations in autism. Nat Genet 47: 582–588. doi: 10.1038/ng.3303
    [168] Brett M, McPherson J, Zang ZJ, et al. (2014) Massively parallel sequencing of patients with intellectual disability, congenital anomalies and/or autism spectrum disorders with a targeted gene panel. PLoS One 9: e93409. doi: 10.1371/journal.pone.0093409
    [169] Grønskov K, Brøndum-Nielsen K, Dedic A, et al. (2011) A nonsense mutation in FMR1 causing fragile X syndrome. Eur J Hum Genet 19: 489–491. doi: 10.1038/ejhg.2010.223
    [170] Vincent JB, Konecki DS, Munstermann E, et al. (1996) Point mutation analysis of the FMR1 gene in autism. Mol Psychiatry 1: 227–231.
    [171] Girirajan S, Dennis MY, Baker C, et al. (2013) Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am J Hum Genet 92: 221–237. doi: 10.1016/j.ajhg.2012.12.016
    [172] Sebat J, Lakshmi B, Malhotra D, et al. (2007) Strong association of de novo copy number mutations with autism. Science 316: 445–449. doi: 10.1126/science.1138659
    [173] Zhao WW (2013) Intragenic deletion of RBFOX1 associated with neurodevelopmental/neuropsychiatric disorders and possibly other clinical presentations. Mol Cytogenet 6: 26. doi: 10.1186/1755-8166-6-26
    [174] Nguyen LS, Kim HG, Rosenfeld JA, et al. (2013) Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders. Hum Mol Genet 22: 1816–1825. doi: 10.1093/hmg/ddt035
    [175] Talkowski ME, Rosenfeld JA, Blumenthal I, et al. (2012) Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149: 525–537. doi: 10.1016/j.cell.2012.03.028
    [176] Turner TN, Hormozdiari F, Duyzend MH, et al. (2016) Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA. Am J Hum Genet 98: 58–74. doi: 10.1016/j.ajhg.2015.11.023
    [177] Amir RE, Van den Veyver IB, Wan M, et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–188. doi: 10.1038/13810
    [178] Hanchard NA, Carvalho CM, Bader P, et al. (2012) A partial MECP2 duplication in a mildly affected adult male: a putative role for the 3' untranslated region in the MECP2 duplication phenotype. BMC Med Genet 13: 71.
    [179] Shibayama A, Cook EH Jr, Feng J, et al. (2004) MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet 128B: 50–53. doi: 10.1002/ajmg.b.30016
    [180] Helander A, Stödberg T, Jaeken J, et al. (2013) Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation. Mol Genet Metab 110: 342–344. doi: 10.1016/j.ymgme.2013.07.002
    [181] Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, et al. (2013) De novo mutations in epileptic encephalopathies. Nature 501: 217–221. doi: 10.1038/nature12439
    [182] McBride KL, Varga EA, Pastore MT, et al. (2010) Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res 3: 137–141. doi: 10.1002/aur.132
    [183] Marui T, Hashimoto O, Nanba E, et al. (2004) Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 131B: 43–47. doi: 10.1002/ajmg.b.20119
    [184] Smalley SL (1998) Autism and tuberous sclerosis. J Autism Dev Disord 28: 407–414. doi: 10.1023/A:1026052421693
    [185] Serajee FJ, Nabi R, Zhong H, et al. (2003) Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism. J Med Genet 40: e119. doi: 10.1136/jmg.40.11.e119
    [186] Kong A, Frigge ML, Masson G, et al. (2012) Rate of de novo mutations and the importance of father's age to disease risk. Nature 488: 471–475. doi: 10.1038/nature11396
    [187] O'Roak BJ, Vives L, Girirajan S, et al. (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246–250. doi: 10.1038/nature10989
    [188] Harlalka GV, Baple EL, Cross H, et al. (2013) Mutation of HERC2 causes developmental delay with Angelman-like features. J Med Genet 50: 65–73. doi: 10.1136/jmedgenet-2012-101367
    [189] Puffenberger EG, Jinks RN, Wang H, et al. (2012) A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder. Hum Mutat 33: 1639–1646. doi: 10.1002/humu.22237
    [190] Deciphering Developmental Disorders Study (2015) Large-scale discovery of novel genetic causes of developmental disorders. Nature 519: 223–228.
    [191] Nava C, Lamari F, Héron D, et al. (2012) Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry 2: e179. doi: 10.1038/tp.2012.102
    [192] Tastet J, Decalonne L, Marouillat S, et al. (2015) Mutation screening of the ubiquitin ligase gene RNF135 in French patients with autism. Psychiatr Genet 25: 263–267. doi: 10.1097/YPG.0000000000000100
    [193] Vourc'h P, Martin I, Bonnet-Brilhault F, et al. (2003) Mutation screening and association study of the UBE2H gene on chromosome 7q32 in autistic disorder. Psychiatr Genet 13: 221–225. doi: 10.1097/00041444-200312000-00005
    [194] Noor A, Dupuis L, Mittal K, et al. (2015) 15q11.2 duplication encompassing only the UBE3A gene is associated with developmental delay and neuropsychiatric phenotypes. HumMutat 36: 689–693.
    [195] Nurmi EL, Bradford Y, Chen Y, et al. (2001) Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. Genomics 77: 105–113. doi: 10.1006/geno.2001.6617
    [196] Chahrour MH, Yu TW, Lim ET, et al. (2012) Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet 8: e1002635. doi: 10.1371/journal.pgen.1002635
    [197] Flex E, Ciolfi A, Caputo V, et al. (2013) Loss of function of the E3 ubiquitin-protein ligase UBE3B causes Kaufman oculocerebrofacial syndrome. J Med Genet 50: 493–499. doi: 10.1136/jmedgenet-2012-101405
    [198] Salyakina D, Cukier HN, Lee JM, et al. (2011) Copy number variants in extended autism spectrum disorder families reveal candidates potentially involved in autism risk. PLoS One 6: e26049. doi: 10.1371/journal.pone.0026049
    [199] Kato T, Tamiya G, Koyama S, et al. (2012) UBR5 gene mutation is associated with familial adult myoclonic epilepsy in a Japanese family. ISRN Neurol 2012: 508308.
    [200] Najmabadi H, Hu H, Garshasbi M, et al. (2011) Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478: 57–63. doi: 10.1038/nature10423
    [201] Hao YH, Fountain MD Jr, FonTacer K, et al. (2015) USP7 acts as a molecular rheostat to promote WASH-dependent endosomal protein recycling and is mutated in a human neurodevelopmental disorder. Mol Cell 59: 956–969. doi: 10.1016/j.molcel.2015.07.033
    [202] Wang K, Zhang H, Ma D, et al. (2009) Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459: 528–533.
    [203] Piton A, Gauthier J, Hamdan FF, et al. (2011) Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry 16: 867–880. doi: 10.1038/mp.2010.54
    [204] De Rubeis S, He X, Goldberg AP, et al. (2014) Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515: 209–215. doi: 10.1038/nature13772
    [205] Sanders SJ, He X, Willsey AJ, et al. (2015) Insights into autism spectrum disorder genomic architecture and biology from 71 Risk Loci. Neuron 87: 1215–1233. doi: 10.1016/j.neuron.2015.09.016
    [206] Lim ET, Raychaudhuri S, Sanders SJ, et al. (2013) Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77: 235–242. doi: 10.1016/j.neuron.2012.12.029
    [207] Liao C, Fu F, Li R, et al. (2013) Loss-of-function variation in the DPP6 gene is associated with autosomal dominant microcephaly and mental retardation. Eur J Med Genet 56: 484–489. doi: 10.1016/j.ejmg.2013.06.008
    [208] Marshall CR, Noor A, Vincent JB, et al. (2008) Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477–488. doi: 10.1016/j.ajhg.2007.12.009
    [209] Prontera P, Napolioni V, Ottaviani V, et al. (2014) DPP6 gene disruption in a family with Gilles de la Tourette syndrome. Neurogenetics 15: 237–242. doi: 10.1007/s10048-014-0418-9
    [210] Zhang Y, Manning BD (2015) mTORC1 signaling activates NRF1 to increase cellular proteasome levels. Cell Cycle 14: 2011–2017. doi: 10.1080/15384101.2015.1044188
    [211] Wang X, Proud CG (2006) The mTOR pathway in the control of protein synthesis. Physiology 21: 362–369. doi: 10.1152/physiol.00024.2006
    [212] Tilot AK, Frazier TW 2nd, Eng C (2015) Balancing proliferation and connectivity in PTEN-associated autism spectrum disorder. Neurotherapeutics 12: 609–619. doi: 10.1007/s13311-015-0356-8
    [213] Sharma A, Hoeffer CA, Takayasu Y, et al. (2010) Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30: 694–702. doi: 10.1523/JNEUROSCI.3696-09.2010
    [214] Busquets-Garcia A, Gomis-González M, Guegan T, et al. (2013) Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med 19: 603–607. doi: 10.1038/nm.3127
  • This article has been cited by:

    1. Qianqian Li, Ankur Jyoti Kashyap, Qun Zhu, Fengde Chen, Dynamical behaviours of discrete amensalism system with fear effects on first species, 2023, 21, 1551-0018, 832, 10.3934/mbe.2024035
    2. Yajie Sun, Ming Zhao, Yunfei Du, Bifurcations, chaos analysis and control in a discrete predator–prey model with mixed functional responses, 2024, 17, 1793-5245, 10.1142/S1793524523500286
    3. Qun Zhu, Fengde Chen, Zhong Li, Lijuan Chen, Global Dynamics of Two-Species Amensalism Model with Beddington–DeAngelis Functional Response and Fear Effect, 2024, 34, 0218-1274, 10.1142/S0218127424500755
    4. MING ZHAO, YAJIE SUN, YUNFEI DU, COMPLEX DYNAMICAL BEHAVIORS OF A DISCRETE MODIFIED LESLIE–GOWER PREDATOR–PREY MODEL WITH PREY HARVESTING, 2025, 33, 0218-3390, 101, 10.1142/S0218339024500451
    5. Manoj Kumar Singh, Arushi Sharma, 2025, 3283, 0094-243X, 040017, 10.1063/5.0265020
  • Reader Comments
  • © 2017 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(7521) PDF downloads(1113) Cited by(1)

Figures and Tables

Figures(2)  /  Tables(2)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog